Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations
The Journal of Allergy and Clinical Immunology | Nov 04, 2017
Most read this week
The Journal of Allergy and Clinical Immunology | Nov 04, 2017